Skip to main content

CITIGROUP INC

Position in PGEN — Precigen, Inc.

CIK 831001 NEW YORK, NY

Position in PGEN

as of Jun 30, 2026 · filed Aug 3, 2026
Position Value
$4,131,855
+$2,655,973 QoQ
Shares Held
724,887
+90.1% QoQ
Ownership
0.202%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#30
of 210 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in PGEN Over Time

Shares Held

Position Value (USD)

Derivatives in PGEN

reported options exposure · as of Dec 31, 2020
CallValue
$67,320
CallShares
6,600
PutValue
$118,320
PutShares
11,600

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

CITIGROUP INC holds $2,085,225,397 across 384 Biotechnology names. PGEN ranks #78 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in PGEN

Export CSV
34 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $4,131,855 724,887
2026-03-31 $1,475,882 381,365
2025-12-31 $483,655 115,707
2025-09-30 $43,963 13,363
2025-06-30 $83,765 58,991
2025-03-31 $145,828 97,872
2024-12-31 $167,259 149,340
2024-09-30 $92,698 97,578
2024-06-30 $53,769 34,032
2024-03-31 $37,236 25,681
2023-12-31 $30,912 23,069
2023-09-30 $4,627 3,259
2023-06-30 $51,254 44,569
2023-03-31 $36,480 34,416
2022-12-31 $65,039 42,789
2022-09-30 $111,357 52,527
2022-06-30 $82,525 61,586
2022-03-31 $206,292 97,769
2021-12-31 $1,813,366 488,778
2021-09-30 $1,226,147 245,721
2021-06-30 $3,205,016 491,567
2021-03-31 $3,424,060 496,961
2020-12-31 $67,320 6,600
2020-12-31 $118,320 11,600
2020-12-31 $418,220 41,002
2020-09-30 $57,914 16,547
2020-09-30 $23,100 6,600
2020-09-30 $40,600 11,600
2020-06-30 $58,383 11,700
2020-06-30 $260,357 52,176
2020-06-30 $32,934 6,600
2020-03-31 $68,340 20,100
2020-03-31 $27,880 8,200
2020-03-31 $585,490 172,203